BIO
Bio-Rad Laboratories Inc
381.00$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -31.9% | +16.0% | -51.8% | +174.2% | +60.4% | +27.8% | +12.2% | -70.4% | +92.8% | +21.4% | +16.9% | |
| – | -12.1% | +8.4% | +4.1% | -7.1% | -2.8% | +3.2% | -3.5% | +2.6% | +6.3% | +3.9% | +9.1% | |
| – | +14.1% | +15.9% | +18.8% | +18.8% | +28.1% | +16.9% | +23.1% | +18.9% | +0.7% | +1.6% | -6.9% | |
| – | – | – | – | -900.3% | – | – | – | – | – | – | – | |
| – | -474.0% | – | – | – | -28.1% | +1,865.8% | -98.7% | -3,021.6% | – | – | – | |
| – | -16.9% | +24.9% | -18.7% | +12.8% | -24.1% | +10.2% | +11.3% | -5.5% | +37.2% | +20.6% | -16.6% | |
| – | -12.4% | +28.2% | -17.9% | +6.5% | +11.7% | -66.5% | +1,022.3% | +53.9% | – | -892.8% | +18.4% | |
| – | – | – | – | – | – | -99.5% | +174,580.7% | +93.3% | +46.8% | – | – | |
| – | -45.3% | +37.0% | -125.9% | +1,575.1% | -42.8% | +257.2% | -50.0% | +331.4% | +98.8% | -52.5% | +45.1% | |
| – | -87.9% | -5.7% | +32.3% | +741.2% | -61.9% | +37,715.6% | -99.3% | – | -100.0% | -20.0% | +25.0% | |
| – | -26.6% | +5.1% | -96.2% | -14,375.7% | -53.2% | +2,198.3% | -89.4% | – | -143.7% | -48.6% | +29.4% | |
| – | -45.8% | -103.7% | – | – | +364.6% | -98.0% | -4,490.3% | – | – | – | -52.8% | |
| – | -46.8% | +2.3% | -114.8% | – | +130.9% | +32.6% | +12.4% | -85.0% | +171.8% | +22.0% | +40.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.